Critical Pressure

About:

Critical Pressure is a virtual bio-pharmaceutical company that develops products to treat vascular dysfunction and shock.

Website: http://www.critical-pressure.com

Twitter/X: @crit_pressure

Top Investors: Medicxi

Description:

Critical Pressure is a provider of drugs designed to treat to treat vascular dysfunction and shock. The company's technology has the potential to change clinical practice without the potentially harmful effects of excess fluid administration and toxicities associated with the currently available catecholamine-based vasoactive agents, providing the possibility of supportive therapy during the critical period of haemodynamic compromise.

Total Funding Amount:

10M GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Cambridgeshire, United Kingdom

Founded Date:

2017-01-01

Contact Email:

info(AT)criticalpressure.com

Founders:

James M. Leiper

Number of Employees:

11-50

Last Funding Date:

2017-11-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai